y e a r s ) , who had r e c e i v e d c r a n i a l i r r a d i a t i o n between two and 1 4 y e a r s e a r l i e r .
p i t u i t a r y a x i s have been d e s c r i b e d i n whom t h e GH response t o a pharmacological t e s t is normal b u t 24 hour G H p r o d u c t i o n is diminished. Therefore we have s t u d i e d GH s e c r e t i o n under physiol o g i c a l c o n d i t i o n s and i n r e s p o n s e t o s t a n d a r d pharmacological s t i m u l i i n 1 4 c h i l d r e n (9-
y e a r s ) , who had r e c e i v e d c r a n i a l i r r a d i a t i o n between two and 1 4 y e a r s e a r l i e r .
A l l 1 4 showed a b l u n t e d G H r e s p o n s e t o a n ITT (1-14 mU/l) and, i n 12, t h e GH r esponse t o a r g i n i n e s t i m u l a t i o n was a l s o subnormal (1.4-19 mU/l). P h y s i o l o g i c a l GI ! s e c r e t i o n was s t u d i e d by measuring i n t e g r a t e d G H c o n c e n t r a t i o n s i n 3 0 minute blood samples c o l l e c t e d over a 2 4 hour p e r i o d by a c o n t i n u o u s withdrawal pump. Compared t o normal c o n t r o l s ( n = 5 ) , t h e i r r a d i a t e d p a t i e n t s showed a s i g n i f i c a n t r ed u c t i o n i n t h e mean i n t e g r a t e d GH c o n c e n t r a t i o n (2.2 : 8.8 mU/l; p 4 0 . 0 0 2 ) , median t o t a l 2 4 hour GE o u t p u t (89-6 : 340.7; p40.002) and t h e median G H o u t p u t d u r i n g t h e f i r s t s i x h o u r s o f s l e e p (32.7 : 210; p<0.002).
There was no s i g n i f i c a~t c o r r e l at i o n between t h e maximum peak GI! response t o e i t h e r pharmacolog i c a l t e s t and t h e t o t a l 2 4 hour G H output. A l l 1 4 c h i l d r e n showed a b l u n t e d GE response t o a n I"IP a s w e l l a s a reduced t o t a l 2 4 hour G H output. T h e r e f o r e we would sugf:est t h a t i n c h i l d r e n s u s p e c t e d of r a d i a t i o n -i n d u c e d GB d e f i c i e~c y pharmacol o g i c a l t e s t s of GV s e c r e t i o n remain u s e f u l , t h e 1"L'I' b e i n e t h e t e s t of choice because of t h e marked r a d i a t i o n s e n s i t i v i t y of t h e hypoglycaeaic stimulus.
GROWTH IMPAIRMENT ASSOCIATED WITH HYPERCORTISOLISM:
7 7 RESPONSE TO GROWTH HORMONE THERAPY. S t u a r t A. I n c h i l d r e n a g e d 7-18 y r ( n = 2 6 ) of n o r m a l s t a t u r e , t h e IC-F, mean +1SD, was 5.9+1.6 p g / d l . I n C u s h i n g ' s d i s e a s e , t h e IC-F w a s 2 0 . 2 + 4 . 7 p g / d l (n=13) (JCEM 54:1072 (JCEM 54: ,1982 .
We have i d e n t i f i e d 5 c h i l d r e n (ages 10-14 y r ) who presented w i t h s h o r t s t a t u r e ( l e s s t h a n 5% f o r a g e ) , s l o w growth ( l e s s than 4.5 cm/yr) and bone age d e l a y ( g r e a t e r than 2 SD f o r age). A l l were e u t h y r o i d and t h e i r s t i m u l a t e d GH and 24-h IC-GX were normal. Vane of t h e p a t i e n t s were obese, had s t r i a e , o r o t h e r c l a s s i c a l p h y s i c a l f i n d i n g s of C u s h i n g ' s syndrome. However, t h e i r IC-F ranged from 13.2-17.2 p g / d l , c l e a r l y i n t h e range of p a t i e n t s w i t h C u s h i n g ' s syndrome. Two of t h e c h i l d r e n w e r e t r e a t e d f o r 8 months w i t h GH (0.2 U/kg t h r e e t i m e s p e r week) and had i n c r e a s e d growth r a t e of 10.6 and 8 c d y r r e s p e c t i v e l y . A t h i r d c h i l d who was t r e a t e d w i t h l e s s G H ( 0 . 1 U/kg t h r e e t i m e s p e r week) i n c r e a s e d h e r growth r a t e from 4. 
How t o p r e d i c t t h e growth outcome of Growth Hormone treatment i n s h o r t c h i l d r e n ?
33 w e l l n u t r i t i o n e d , h e a l t h y c h i l d r e n of s h o r t stature(<-2SD) with r e t a r d e d bone age were a f t e r e x t e n s i v e investigation p u t o n Growth Hormone (GH) treatment (Crescormone 0 , l IU/kg and day s c ) f o r one year. The p r e d l c t l o n value of different parameters were evaluated a g a i n s t t h e e f f e c t of GH-treatment on growth v e l o c i t y . 24 c h i l dren rernainedprepubertal and were statistically a n a l y z~d . Results: Growth v e l o c i t y increased from 4,O 0 , 9 t o 7 , 2 ' 1 , 4 cm/year ( -3 , l t o -2 , 6 SD). Boneage was not a c c e l e r a t e d . This i nc r e a s e i n growth r a t e c o r r e l a t e d t o an i n c r e a s e from day 0 t o day 5-10 i n serumlevels of IGF I/SMA ( r = 0 , 8 p <0,001), i n IGF I I / s ( r = 0 , 7 ; p < 0 , 0 1 ) , In p r o c o l l a q e n -I I I / s ( r = 0 , 7 ; p <0,001) and t h e l e v e l s of a l k a l i n e p h o s p h a t a s e / s . No c o r r e l a t i o n was found t o t h e a r e a under t h e curve o r t h e rnax value of GH a f t e r provocative t e s t s a s ~n s u l i n -a r g i n l n , Catapressan, s l e e p or e x e r c l s e . N e i t h e r with t h e t o t a l amount of s e c r e t e d GH over 24 h o r wlth t h e s e c r et o r y p a t t e r n of 24-h-GH. However, t h e c h l l d r e n were s e l e c t e d t o treatment only i f they had lower amount of 24-h-GH than Cast growlnq c h l l d r e n . Conclusion: These s h o r t c h i l d r e n , with low amount of 24-h-GH but normal l n c r e a s e of GH a f t e r provocative t e s t s , n e a r l y doubled t h e i r growth r a t e on GH-treatment f o r one year. IGF I/SI.IA,IGF 11, procollagen and ALP showed p r e d l c t l n g value. How t o b e s t combine them a s d l a g n o s t l c t o o l s i s now under e v a l u a t i o n . llowever, ~n -creased f i n a l helght remalns t o be seen.
GROWTH RESPONSE TO GROWTH HORMONE(GH) THERAPY I N PR1:-24 PUBERTAL CHILDREN WITH PARTIAL AND TOTAL GH DEFICIENCY Jan-Maarten Wit, J.Leo Van den Brande, University cf U t r e c h t , Department of P e d i a t r i c s , U t r e c h t , The Netherlands.
According t o GH-peak v a l u e s i n provocation t e s t s , G H d e f l c i e ncy (GHD) h a s been subdivided i n t o a " t o t a l " (GH peak <8mU/1) and a " p a r t i a l " (GH peak 8-15 m U / 1 ) form by v a r i o u s l n v e s t i q a t o r s .
C o n f l i c t i n g d a t a on t h e response t o hGH therapy have been repost e d . W e s t u d i e d growth a c c e l e r a t i o n i n t h e 1 s t and 2nd y e a r of G H therapy i n p r e p u b e r t a l c h i l d r e n with v a r l o u s forms of GHD.
Group I : p a r t i a l GHD (PGHD): a t l e a s t one GH peak between 8-15 m U / 1 ( n = 1 4 ) , 10 without ( I a ) and 4 with TSH deficiency ( I b ) . Group 11: i s o l a t e d t o t a l GHD ( n = 9 ) . Group 111: t o t a l GH-and TSHd e f i c i e n c y ( n = 8 ) . Group I V : m u l t l p l e p i t u i t a r y d e f i c i e n c y ( n = l l ) . A l l p a t i e n t s r e c e l v e d 4 I U twice a week i . m . The r e s u l t s a r e shown i n t h e t a b l e (mean + S o ) .
Group
I a I b I I 111 IV Age ( y e a r s ) 11.7'2.5 8.9'4.6 8.7'2.8 7.6'3.0 10.7'2.8 Acceleration 1 s t y r 4.0c1.0 3 . 1 t 1 . 3 3.6'1.5 7.2k3.2 3.221.9 (cm/yr/yr) 2nd y r 1.9c0.9 2.1'0.2 1 . 0 t 1 . 0 2.8'2.3 1 . 8 i 1 . 7
There was no d i f f e r e n c e between t h e growth response of t o t a l and p a r t i a l GH-deficiency. Group 111 showed t h e g r e a t e s t a c c e l e r a t i c n .
In group I and 11 combined, stepwise m u l t i p l e regression a n a l y s i s showed t h a t 1 s t y e a r growth a c c e l e r a t i o n d l d n o t show any SignlP f l c a n t c o r r e l a t i o n with a number of c l i n l c a l parameters. 2nd y e a r growth a c c e l e r a t i o n was most c l o s e l y r e l a t e d t o pre-treatment growth v e l o c l t y ( r = 0 . 7 1 ) , b
u t a d d l t i o n of h e i g h t (SDS) and skirlf o l d (SDS) i n c r e a s e d t h e c o r r e l a t i o n coefficient t o 0.92.

FINAL HEIGHT OF PATIENTS WITH IDIOPATHIC PITUITARY GROWTH FAILURE. CORRELATION WITH 5 ADULT HEIGHT PREOICTION METHODS AT THE ONSET
25 AN0 AFTER ONE YEAR OF TREATMENT. Bruno L e h e u~, Yolande P a l a n d r i , l i c h e l P i e r s o n . M e d i c a l School, Department o f P e d i a t r i c s , Nancy. France.
The a v a i l a b i l t y o f hGH a l l o w s s u c c e s s f u l t r e a t m e n t o f i d i o p a t h i c p i t u i t a r y g r o w t h f a i l u r e (GH d e f i c i e n c y ) . F i n a l h e i g h t (FH) i s c o r r e l a t e d w i t h s i d p a r e n t h e i g h t , bone age (8A) d e f i c i t and t h e i n c r e a s e i n h e i g h t v e l o c i t y . A d u l t h e i g h t p r e d i c t i o n (AHP) methods a r e based e i t h e r on p a r e n t a l h e i g h t o r on c l i n i c a l data. T h e r e f o r e AHP may be u s e f u l t o p r e d i c t FH e a r l y i n t h e course o f t h e t r e a t m e n t o f GH d e f i c i e n c y . Twenty one o f o u r p a t i e n t s have a l r e a d y reached FH. 11 ( 8 H, 3 F) u e r e c l a s s i f i e d as GH and g o n a d o t r o p h i n d e f i c i e n t (CD), 1 0 ( 9 H, 1 F) as i s o l a t e d GH d e f i c i e n c y ( I D ) . F i v e d i f f e r e n t AHP methods uere used on r e t r o s p e c t i v e d a t a : T a n n e r ' s T a r g e t H e i g h t ( T T H ) , CUP NANCY T a r g e t H e i g h t (NTH) ( l o c a l p o p u l a t i o n a n a l y s i s ) (*). Bayley-Pinneau (BP), Tanner-Yhitehouse 1975 (TY). Tanner 1983 ( T L ) . The c a l c u l a t i o n s mere
done a t the onset ( 0 ) and a f t e r 1 year o f t r e a t m e n t ( + 6 weeks) ( + I ) u s i n g a spec i f i c s o f t w a r e r u n n i n g on a APPLE I I e 64K (*). FH ua; s i g n i f i c a n t l y c o r r e l a t e d Hypopituitary boys (n=29) t r e a t e d w i t h hGti (18 t o 24 IUIweek) were s t u d i e d before and during soontaneous puberty (SP, n=9) o r puberty induced with t e s t o s t e r o n e e n a n t h a t e , 100 mglmonth (TIP, n=20). At o n s e t of puberty, bone age (BA, TN2) v a r i e d between 11.2 and 15.4 y r s . T o t a l h e i g h t g a i n d u r i n g puberty (mean : 1 7 . 2 cm) was n o t s i g n i f i c a n t l y r e l a t e d (r=-0.38) t o B A o t o n s e t of p l r b e r t y . I n c o n t r a s t , B A increment (ABA) during puberty was negat i v e l y r e l a t e d (r=-0.92) t o B A a t o n s e t of puberty. F i n a l h e i g h t (FH) was a t t a i n e d i n 21 o u t of 29 p a t i e n t s . Mean FH was 157.2 cm a f t e r SP and 165.5 cm a f t e r TIP. FH was a d i r e c t f u n c t i o n of par e n t ' s h e i g h t (r=0.61). A f t e r allowing f o r p a r e n t ' s h e i g h t , FH was found t o be s i g n i f i c a n t l y r e l a t e d t o h e i g h t a t o n s e t of pub e r t y (r=0.71) and a d u l t h e i g h t p r e d i c t e d (Tld mark 11) a t o n s e t of puberty ( r = 0 . 8 1 ) . In c o n t r a s t , FH d i d not change i n r e l a t i o n t o B A a t o n s e t of puberty ( r = 0 . 2 8 ) . At t h e end of growth, a decreased h e i g h t v e l o c i t y (HV) can be expected from previous H V (r=0.57) and from h e i g h t achieved a s a percentage of p r e d i c t e d FH (r=-0.56) but n o t from B A a t t h a t time.
Ide conclude t h a t , i n h y p o p i t u i t a r y boys w i t h SP and TIP, 1.8A a t o n s e t of puberty does not p r i m a r i l y i n f l u e n c e H V d u r i n g p u b e r t y and FH, 2. a t onset of p u b e r t y , FH may be p r e d i c t e d although somewhat underestimated, 3. b e s i d e s p a r e n t ' s h e i g h t , the major f a c t o r i n f l u e n c i n g FH i s p a t i e n t ' s h e i g h t a t o n s e t of puberty.
